31.51
4.75%
+1.43
Pacira BioSciences Inc (PCRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
10.56%
181.24
|
163.93 | 169.47 | 160.34 | 171.96 |
Cost Of Revenue |
19.98%
47.69
|
39.75 | 48.21 | 49.02 | 61.92 |
Gross Profit |
7.55%
133.55
|
124.18 | 121.26 | 111.32 | 110.04 |
Operating Expenses
|
5.70%
100.38
|
106.45 | 81.38 | 114.41 | 119.93 |
Interest Income/Expense |
2.19%
3.388
|
3.464 | 3.865 | 9.589 | 11.04 |
Benefits Costs and Expenses |
0.14%
147.52
|
147.32 | 131.61 | 186.81 | 190.02 |
Costs And Expenses |
1.28%
148.08
|
146.21 | 129.59 | 163.43 | 181.85 |
Operating Income/Loss |
87.17%
33.17
|
17.72 | 39.88 | -3.091 | -9.893 |
Nonoperating Income/Loss |
149.29%
0.552
|
-1.12 | -2.023 | -23.38 | -8.175 |
Income/Loss From Continuing Operations Before Tax |
103.12%
33.72
|
16.60 | 37.85 | -26.47 | -18.07 |
Income Tax Expense/Benefit, Deferred |
34.33%
6.601
|
4.914 | 11.44 | -7.342 | -10.84 |
Income Tax Expense/Benefit |
54.10%
8.85
|
5.743 | 12.09 | -6.938 | -7.966 |
Income/Loss From Continuing Operations After Tax |
129.05%
24.87
|
10.86 | 25.76 | -19.54 | -10.10 |
Net Income/Loss
|
129.05%
24.87
|
10.86 | 25.76 | -19.54 | -10.10 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.85%
0.071
|
46.42 | 46.09 | 45.95 | 0.121 |
Diluted Average Shares |
89.18%
5.636
|
52.07 | 52.05 | 45.95 | -5.682 |
Basic Earnings Per Share |
134.78%
0.54
|
0.23 | 0.56 | -0.43 | -0.22 |
Diluted Earnings Per Share |
126.09%
0.52
|
0.23 | 0.51 | -0.43 | -0.22 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):